US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.27

+0.82002.03%

Post-market: 41.270.00000.00%18:39 EDT

Volume:1.26M

Turnover:52.12M

Market Cap:1.06B

PE:- -

High:41.37

Open:40.60

Low:40.60

Close:40.45

52wk High:43.52

52wk Low:28.77

Shares:25.80M

Float Shares:25.80M

Volume Ratio:15.04

T/O Rate:4.90%

Dividend:0.29

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

Perspective Therapeutics [212Pb]VMT01 Melanoma Trial Data Set for SITC 2026 Presentation

Correction: Top Midday Decliners

MT Newswires Live

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses on the Day

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Sector Update: Healthcare

MT Newswires Live

AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FTXH/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":41.27,"timestamp":1791576000000,"preClose":40.45,"halted":0,"volume":1263440,"hourTrading":{"tag":"盘后","latestPrice":41.27,"preClose":41.27,"latestTime":"18:39 EDT","volume":685055,"amount":28272142.39,"timestamp":1791585556641,"change":0,"changeRate":0,"amplitude":0.003392},"delay":0,"changeRate":0.020271940667490735,"floatShares":25800002,"shares":25800002,"eps":0,"marketStatus":"Market Closed","change":0.82,"latestTime":"10-09 16:00:00 EDT","open":40.6,"high":41.37,"low":40.6,"amount":52122476.824159995,"amplitude":0.019036,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.45,"sharesOutstanding":850002,"nav":40.46,"aum":1045891080.92,"dividendRate":0.007056,"bidAskSpread":0.001333,"preHourTrading":{"tag":"盘前","latestPrice":40.45,"preClose":40.45,"latestTime":"07:38 EDT","volume":1,"amount":40.45,"timestamp":1791545911139,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":41.27,"preClose":41.27,"latestTime":"18:39 EDT","volume":685055,"amount":28272142.39,"timestamp":1791585556641,"change":0,"changeRate":0,"amplitude":0.003392},"volumeRatio":15.04134634604464,"impliedVol":0.216,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25800002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":15.04134634604464,"shares":25800002,"dividePrice":0.2912,"high":41.37,"amplitude":0.019036,"preClose":40.45,"low":40.6,"week52Low":28.77,"pbRate":"--","week52High":43.52,"institutionHeld":0,"latestPrice":41.27,"eps":0,"divideRate":0.007056,"volume":1263440,"delay":0,"ttmEps":0,"open":40.6,"prevYearClose":32.9401,"prevWeekClose":40.73,"prevMonthClose":41.47,"prevQuarterClose":41.47,"fiveDayClose":40.73,"twentyDayClose":40.4666,"sixtyDayClose":38.5244},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-09-24","symbol":"FTXH","amount":0.0113,"announcedDate":"2026-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-24","defaultRemindTime":1790256600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-24","currency":"USD","dateTimestamp":1790222400000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672465897","title":"Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca","url":"https://stock-news.laohu8.com/highlight/detail?id=2672465897","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672465897?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:06","pubTimestamp":1790967978,"startTime":"0","endTime":"0","summary":"Lilly says FDA approves expanded first-line CLL/SLL use for JaypircaFDA cleared Lilly’s Jaypirca (pirtobrutinib) for first-line treatment of adults with CLL/SLL with no known 17p deletion.Decision exp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3s639g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","SG9999014914.USD","SG9999014906.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","LU2089283258.USD","LU2168564149.EUR","LU1551013342.USD","LU2360106947.USD","ILDR","IE0004445239.USD","LU1145028129.USD","BK4588","LU1061106388.HKD","LU0823434740.USD","TRUH","LU2361044949.HKD","LU0320765992.SGD","BK4585","CURE","LU2462591350.SGD","SG9999018865.SGD","LU2471134879.HKD","IE00BK4W5L77.USD","LU1720051017.SGD","BK4581","PJP","LU0689472784.USD","LU0456855351.SGD","LU2756315664.SGD","LU2746668461.USD","LU0094547139.USD","LU2028103732.USD","LU0471298694.HKD","LU1035775433.USD","LU2213496289.HKD","LLYZ","LU1868837136.USD","LU1868837300.USD","LU0234572021.USD","LU1989771016.USD","AGNG","LU2089984988.USD","LU0289739699.SGD","LU0640476718.USD","SG9999015952.SGD","LU2468319806.SGD","LU0471298777.SGD","LU2491050154.USD","LU2552382215.SGD","PPH","LU0061475181.USD","LU1804176565.USD","BK4533","LU2750360997.AUD","IE00BKPKM429.USD","LU2168564495.EUR","LLY","LU2896262040.SGD","IE00BJJMRY28.SGD","IE00BJT1NW94.SGD","SG9999001176.USD","LU2357305700.SGD","LU0820562030.AUD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","IE00B1XK9C88.USD","LU0158827948.USD","LU1979441026.SGD","LU2112291526.USD","LU1691799644.USD","LU2462157665.USD","LU1069344957.HKD","LU0708995401.HKD","RXL","LU0345770993.USD","LU1323610961.USD","SG9999015978.USD","SGXZ99366536.SGD","LU1280957306.USD","LU2168564065.EUR","LU0114720955.EUR","FTXH","LU2168563687.JPY","LU0820561909.HKD","IE00B4JS1V06.HKD","LU1712237335.SGD","LU2361044865.SGD","LU2023251221.USD","IE0009355771.USD","LU2361045086.USD","SGXZ51526630.SGD","LU1267930730.SGD","BK4007","LLII","LU0203202063.USD","LU1023059063.AUD","LU1064131342.USD","LU1093756168.USD","IE0005OL40V9.USD","LU1551013425.SGD","VHT","LU0079474960.USD","LU2271345857.HKD","LU2111349929.HKD","LU0345770308.USD","LU2471134796.USD","IE00BFTCPJ56.SGD","LU2106854487.HKD","SG9999015945.SGD","LU0174119429.USD","LU2324357040.USD","LU0353189680.USD","LU1623119135.USD","SG9999018857.SGD","TMED","CANC","LU1868836591.USD","LU2602419157.SGD","BK4534","LU0158827781.USD","LU2087625088.SGD","LU2756315318.SGD","SG9999014898.SGD","SGXZ81514606.USD","LU2063271972.USD","XLV","LU0122379950.USD","LU0198837287.USD","IE00BFSS7M15.SGD","IE00B1BXHZ80.USD","LU0353189763.USD","LU0385154629.USD","LU1988902786.USD","LU2108987350.USD","LU2417539215.USD","LU0943347566.SGD","LU1366192091.USD","LU2236285917.USD","LU0820561818.USD","LU0266013472.USD","LU0823434583.USD","SG9999015986.USD","LU1232071149.USD","LU0683600562.USD","LU0889565916.HKD","MEDI","SG9999001176.SGD","BK4516","IE00BFSS8Q28.SGD","LU0058720904.USD","IE0004445015.USD","LU2750360641.GBP","MHIP","LU0882574055.USD","LU1814569148.SGD","LU1974910355.USD","LU0672654240.SGD","LU2237443465.HKD","LU2265009873.SGD","ELIS","LU0238689110.USD","WDNA","LU0466842654.USD","SG9999014880.SGD","JDOC","IE00BN29S564.USD","LU1868836914.USD","IE00BWXC8680.SGD","LU1127390331.HKD","SG9999013999.USD","ELIL","LU0210536198.USD","LU0354030511.USD","LU2471134952.CNY","IE00BK4W5M84.HKD","OZEM","LU2552382132.HKD","LU0882574139.USD","LU2471134523.USD","IE0001KFT4U8.USD","LU2264538146.SGD","LU2456880835.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU0109394709.USD","LU0320765059.SGD","LU1548497426.USD","LU0787776722.HKD","LU2237443622.USD","LU0256863902.USD","LU1629891620.HKD","IYH","LU2023250504.SGD","LU0964807845.USD","LU0109391861.USD","LU0096364046.USD","LLYX","LU0786609619.USD","LU2461242641.AUD","IE00B775H168.HKD","SG9999017495.SGD","IHE","LU2211815571.USD","IE0002141913.USD","LU2491049909.HKD","LU2491050071.SGD","SGXZ31699556.SGD","LU1720051108.HKD","IXJ","LU0225283273.USD","LU2237443549.SGD","SGXZ57979304.SGD","LU0354030438.USD","LU2023250330.USD","BK4599","LU1983299246.USD","LU0823416689.USD","LU2237438978.USD","MEDX","LU2168564222.USD","LU0106261372.USD","LU2552382058.USD","IE00BJLML261.HKD","LU0203201768.USD","LU0006306889.USD","LU1868836757.USD","LU2089284900.SGD","IE00BKDWB100.SGD","LU2746668974.SGD","LU1057294990.SGD","LU0316494557.USD","GDOC","LU2237443382.USD","IE00B4R5TH58.HKD","LU0133085943.USD","HRTS","LU0323591593.USD","THNR","LU1917777945.USD","LU0097036916.USD","LU2237443895.HKD","LU2237443978.SGD","FHLC","LU1291159041.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672874637","title":"Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874637?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:05","pubTimestamp":1790967939,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA8VSLSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","LU2361044865.SGD","SGXZ81514606.USD","LU2750360997.AUD","BK4534","IE00BKDWB100.SGD","LU2360106947.USD","LU2896262040.SGD","LU0823416689.USD","LU0061475181.USD","LU0122379950.USD","LU0198837287.USD","BK4581","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU1720051017.SGD","SGXZ51526630.SGD","SGXZ31699556.SGD","CANC","LU2236285917.USD","LU0266013472.USD","LU0353189680.USD","HRTS","LU0158827781.USD","IE00BJT1NW94.SGD","LU0225283273.USD","LU2462591350.SGD","IXJ","IE00B1BXHZ80.USD","LU0432979614.USD","LU2168564222.USD","LU1551013342.USD","LU1983299246.USD","LU0345770308.USD","LU1917777945.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BWXC8680.SGD","LU0345770993.USD","CURE","LU2417539215.USD","LU1035775433.USD","IE00B1XK9C88.USD","LU0787776722.HKD","TMED","SG9999015945.SGD","AGNG","BK4588","IE00BKPKM429.USD","LU2237443382.USD","LU0820562030.AUD","LU2265009873.SGD","LU1868836757.USD","SG9999014880.SGD","LU2746668461.USD","LU1691799644.USD","LU0320765992.SGD","LU1551013425.SGD","BK4007","XLV","LU2461242641.AUD","SG9999013999.USD","LU2756315318.SGD","LU0238689110.USD","SGXZ57979304.SGD","BK4599","LU2111349929.HKD","LU2112291526.USD","FTXH","LU0820561909.HKD","LU2211815571.USD","LU2471134952.CNY","LU0640476718.USD","LU0683600562.USD","LU2361045086.USD","LU0889565916.HKD","LU1548497426.USD","SG9999017495.SGD","LU1814569148.SGD","LU1868836591.USD","LU1974910355.USD","WDNA","LU1868836914.USD","IE00B4JS1V06.HKD","LU0256863811.USD","LU1868837136.USD","LU2491050154.USD","LU1720051108.HKD","SG9999014906.USD","LU1804176565.USD","IE00BK4W5M84.HKD","LU0943347566.SGD","IE00BFSS7M15.SGD","SG9999018857.SGD","BK4533","PPH","LU0354030511.USD","LU2237438978.USD","LU1989771016.USD","LU0471298694.HKD","LU2552382058.USD","IE00BJJMRY28.SGD","IE0005OL40V9.USD","LU0109391861.USD","LU0354030438.USD","LU1623119135.USD","ELIL","LU0133085943.USD","LU2089284900.SGD","LU1868837300.USD","LU2213496289.HKD","BK4516","LU2468319806.SGD","LU2237443549.SGD","LLY","LU2471134879.HKD","THNR","LU0114720955.EUR","LU1069344957.HKD","LU1323610961.USD","LU2168564149.EUR","IE00BJJMRX11.SGD","LU2491050071.SGD","LU2089984988.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2168564495.EUR","LU0234572021.USD","GDOC","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU0174119429.USD","LU2750360641.GBP","LU2456880835.USD","LU1127390331.HKD","LU0708995401.HKD","TRUH","SG9999014898.SGD","LU1057294990.SGD","LU2168563687.JPY","LU0079474960.USD","LLII","IE00B4R5TH58.HKD","LU1712237335.SGD","LU0417517546.SGD","SGXZ99366536.SGD","LU1988902786.USD","LU2357305700.SGD","PJP","LU0820561818.USD","LU2237443978.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2602419157.SGD","LU0385154629.USD","LU2462157665.USD","MEDI","JDOC","LU2089283258.USD","IE0001KFT4U8.USD","LU0289739699.SGD","LU2063271972.USD","LU2108987350.USD","IE0004445015.USD","ILDR","LU0316494557.USD","LU1093756325.SGD","LU2264538146.SGD","LLYZ","LU0096364046.USD","LLYX","LU0094547139.USD","LU0471298777.SGD","LU0823434583.USD","LU1093756168.USD","IE0004445239.USD","LU0964807845.USD","MHIP","LU0256863902.USD","LU2237443895.HKD","LU1629891620.HKD","LU0106261372.USD","LU1232071149.USD","ELIS","LU0323591593.USD","LU0882574055.USD","LU2023250330.USD","LU2271345857.HKD","LU0456855351.SGD","IHE","LU0006306889.USD","LU0320765059.SGD","LU0672654240.SGD","LU1366192091.USD","LU2028103732.USD","LU1280957306.USD","LU0466842654.USD","LU2552382132.HKD","LU0882574139.USD","LU2168564065.EUR","IE00BFSS8Q28.SGD","SG9999015986.USD","LU2237443465.HKD","LU0097036916.USD","LU0689472784.USD","LU2087625088.SGD","LU2471134523.USD","VHT","LU0058720904.USD","BK4585","IYH","LU0353189763.USD","LU1291159041.SGD","LU1979441026.SGD","LU1061106388.HKD","LU0823434740.USD","LU1267930730.SGD","LU2324357040.USD","LU0203201768.USD","LU2746668974.SGD","MEDX","IE00B7KXQ091.USD","IE00B775H168.HKD","OZEM","LU0203202063.USD","SG9999001176.USD","SG9999015978.USD","FHLC","SG9999014914.USD","LU2552382215.SGD","LU2361044949.HKD","LU2756315664.SGD","LU2023251221.USD","LU0109394709.USD","LU2237443622.USD","LU2491049909.HKD","RXL","LU1023059063.AUD","LU0158827948.USD","SG9999015952.SGD","SG9999018865.SGD","SG9999001176.SGD","IE00BN29S564.USD","LU0786609619.USD","IE0009355771.USD","LU2471134796.USD","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672034743","title":"Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672034743","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672034743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:05","pubTimestamp":1790960723,"startTime":"0","endTime":"0","summary":"Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' (GILD) anito-cel approaches a potential approval and Johnson & Johnson's (JNJ) Tec-","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IYH","FTXH","IE00BLSP4239.USD","LEGN","XLV","BBH","LU0426417589.USD","LU1585245621.USD","MEDI","TMED","LU2129689605.HKD","LU1162221912.USD","FHLC","IE00B42XCP33.USD","GILD","LABU","LU1221951046.USD","IXJ","JNJ","PJP","MEDX","IE00BKVL7J92.USD","LU0545039389.USD","IE0034235303.USD","VHT","LU0859254822.USD","LU0345769631.USD","LU1261432733.SGD","TRUH","IBB","XBI","TBXU","LU1057294990.SGD","CANC","IBBQ","IHE","LU0545562505.USD","BK4550","LU0889566641.SGD","MEMS","GDOC","JDOC","RXL","SG9999001440.SGD","BK4504","IE00BLSP4452.SGD","LU0320765992.SGD","BMED","LU0345770308.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743169","title":"AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743169","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743169?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958623,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest study, NCT05317494, tracks how its leukemia drug Venetoclax wor...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-venetoclax-aml-study-in-greece-what-the-latest-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999011175.SGD","LU0395794307.EUR","GLAM","ABBV","LU0289961442.SGD","IE00BSNM7G36.USD","IXJ","LU1244550494.USD","LU1989772840.SGD","ISBC","TRUH","LU0942090050.USD","LU0198837287.USD","IE00BLSP4452.SGD","VHT","IE00B19Z3581.USD","IE0002270589.USD","LU1732799900.SGD","XLV","LU1989771016.USD","LU2129689605.HKD","MEDX","RXL","LU0310799852.SGD","LU0289739699.SGD","LU2023251221.USD","FHLC","LU1934455863.HKD","IYH","LU0029864427.USD","LU2237443549.SGD","LU2129689514.USD","PJP","LU0170899867.USD","FTXH","LU2125909247.SGD","IE00BN8TJ469.HKD","IE00BDGV0183.EUR","AGNG","IE00BVYPNW00.USD","LU1839511570.USD","IE00B42XCP33.USD","LU0234572021.USD","LU2133065610.SGD","LU1023059063.AUD","LU0965509010.AUD","LU0985320562.USD","PPH","JDOC","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672074840","title":"Perspective Therapeutics [212Pb]VMT01 Melanoma Trial Data Set for SITC 2026 Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2672074840","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672074840?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:46","pubTimestamp":1790956004,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics [212Pb]VMT01 melanoma trial data set for SITC 2026 presentationPerspective Therapeutics flagged [Pb]VMT01 phase I/IIa melanoma data accepted for presentation at SITC 2026 in P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8GnXHM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","BCDF","LU1670711123.USD","LU2360032135.SGD","NDAQ","LU1670710588.SGD","LU1670711040.USD","LU0432979614.USD","LU1236620834.HKD","LU1989771016.USD","IE00BN0W2V16.EUR","LU0314104364.USD","LU0306807586.USD","SG9999014005.SGD","LU0306806265.USD","LU0225284248.USD","LU2210150020.SGD","BMY","LU2210149790.SGD","IHE","CATX","LU2596442595.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0096364046.USD","BK4581","IE00B2B36J28.USD","LU2125154778.USD","FTXH","LU1032466523.USD","LU1236620750.USD","LU2242652126.USD","SG9999014039.USD","LU1718418525.SGD","IE00BQXX3D17.EUR","LU1883839398.USD","BK4588","LU0456855351.SGD","IE00B64PRP62.GBP","BK4007","IE00BGHQF748.EUR","BK4534","LU0321505868.SGD","LU1093756168.USD","LU0868494617.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","LU0237698245.USD","LU2133065610.SGD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672339714","title":"Correction: Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672339714","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672339714?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:22","pubTimestamp":1790943727,"startTime":"0","endTime":"0","summary":"Corteva  said Thursday that a federal court denied California's request to temporarily block the planned separation of its seed business into a new publicly traded company, Vylor .In a separate announcement, Vylor said it completed its separation from Corteva and will begin trading as an independent public company on the New York Stock Exchange.Corteva shares slumped 84% as intraday trading volume catapulted to nearly 63.5 million from a daily average of about 4.45 million.Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909  into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial.Foghorn shares sank 20% as intraday trading volume soared to nearly 11.8 million from a daily average of roughly 380,000.Paramount Skydance  CEO David Ellison has asked CNN CEO Mark Thompson to continue after Paramount completes its acquisition of Warner Bros. Discovery , The Wall Street Journal reported Thursday, citing people famil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELIL","LU2552382132.HKD","LU0061475181.USD","LU0708995401.HKD","IE0001KFT4U8.USD","LU0130102774.USD","LU0198837287.USD","LU1548497426.USD","LU0980610538.SGD","LU2106854487.HKD","SG9999018857.SGD","CTVA","SG9999013999.USD","SGXZ57979304.SGD","CANC","LU0612318971.USD","LU1551013342.USD","IE00BJLML261.HKD","LU2213496289.HKD","ILDR","IE0009355771.USD","LU0225283273.USD","LU2360106947.USD","BK4007","LU0203201768.USD","LU0006306889.USD","LU0320765059.SGD","LU0630314457.HKD","LU0466842654.USD","LU0882574139.USD","LU2756315664.SGD","LU2471134952.CNY","IE00BFTCPJ56.SGD","PBJ","LU1712237335.SGD","GB00BDT5M118.USD","LU2461242641.AUD","IE00BKPKM429.USD","LU0149725797.USD","LU1629891620.HKD","PYZ","IE00BKDWB100.SGD","LU2896262040.SGD","LU0323591593.USD","LU0133085943.USD","LU0820561818.USD","LU0889565916.HKD","SG9999014906.USD","LU0345770993.USD","SG9999015978.USD","SG9999017495.SGD","LU1551013425.SGD","LU2089284900.SGD","IHE","LU2087625088.SGD","LU1023059063.AUD","LU1989771016.USD","LU2168564222.USD","LU2456880835.USD","LU2168564495.EUR","LU2491050071.SGD","LU0210536198.USD","LU0456855351.SGD","LU2361045086.USD","LU2236285917.USD","IE00BN29S564.USD","LU0266013472.USD","VYLR","LU0432979614.USD","TRUH","LU2750360997.AUD","LU2237443895.HKD","BK4581","LU2462591350.SGD","AGNG","BK4516","IE00B2B36J28.USD","IE00B7KXQ091.USD","IE0004445239.USD","LU0316494557.USD","LU0353189680.USD","LU0683600562.USD","LU1983299246.USD","LU0256863811.USD","FTXH","LU1720051108.HKD","LU0345770308.USD","LU0096364046.USD","LU0158827781.USD","IE00BJT1NW94.SGD","LU1127390331.HKD","IE00BFSS7M15.SGD","LU2237443549.SGD","LU0079474960.USD","LU2471134796.USD","SGXZ31699556.SGD","LU2271345857.HKD","WBD","TMED","IE00B775H168.HKD","LLII","BK4585","LU1868836591.USD","IE00BJJMRX11.SGD","LU0786609619.USD","LU1093756325.SGD","LU1201861249.SGD","BK4139","BK4598","BK4535","LU0823434583.USD","IXJ","LU2089283258.USD","IE00B1XK9C88.USD","LU2264538146.SGD","SKYD","IE00BK4W5M84.HKD","IE00BK4W5L77.USD","LU0289739699.SGD","LU0612318385.USD","LU0106261372.USD","LU1506573853.SGD","LU1232071149.USD","IE0004445015.USD","IE00BJJMRZ35.SGD","LLYX","LU1069344957.HKD","LU1064131342.USD","LU2552382058.USD","PJP","LU0094547139.USD","BK4588","LU1145028129.USD","LU0174119429.USD","IE0002141913.USD","MHIP","LU2491050154.USD","IE0005OL40V9.USD","IE00B4R5TH58.HKD","LU0256863902.USD","LU0300736492.USD","LU0820562030.AUD","LU1804176565.USD","LU2237443978.SGD","LU0109394709.USD","THNR","ELIS","PPH","LU0823434740.USD","LU2168563687.JPY","RXL","LU0234572021.USD","SG9999018865.SGD","SG9999015986.USD","LU2750360641.GBP","PSKY","LLYZ","LU1868836914.USD","LU2471134879.HKD","FHLC","OZEM","LU2602419157.SGD","FHTX","LLY","FTAG","GDOC","LU0417517546.SGD","LU0820561909.HKD","LU2237443382.USD","LU0114720955.EUR","LU2028103732.USD","LU0109391861.USD","SG9999014914.USD","LU0471298777.SGD","LU0097036916.USD","LU2168564065.EUR","LU0477156953.USD","IE00B1BXHZ80.USD","LU2211815571.USD","IE00BWXC8680.SGD","LU0130517989.USD","LU0385154629.USD","SGXZ81514606.USD","LU0471298694.HKD","JDOC","LU1720051017.SGD","LU1917777945.USD","BK4534","LU0787776722.HKD","LU2471134523.USD","LU2023251221.USD","VHT","MEDI","LU2237443465.HKD","LU0345780950.USD","LU1814569148.SGD","SG9999002521.SGD","LU0964807845.USD","IYH","SG9999014880.SGD","LU1979441026.SGD","SGXZ51526630.SGD","LU2361044949.HKD","SG9999015945.SGD","LU0354030511.USD","LU2468319806.SGD","LU2023250504.SGD","LU1868837300.USD","LU2357305700.SGD","LU1035775433.USD","LU1291159041.SGD","LU1323610961.USD","CURE","LU1057294990.SGD","LU2089984988.USD","LU2108987350.USD","LU1061106388.HKD","LU2265009873.SGD","SG9999015952.SGD","IE00BFSS8Q28.SGD","LU1988902786.USD","LU2417539215.USD","VEGI","LU0354030438.USD","LU0238689110.USD","LU0689472784.USD","BK4599","LU0345781412.USD","LU2237443622.USD","IE00B4JS1V06.HKD","BK4533","LU1868837136.USD","LU2023250330.USD","LU0203202063.USD","LU2361044865.SGD","LU2462157665.USD","LU0943347566.SGD","LU0882574055.USD","LU1623119135.USD","LU2491049909.HKD","BK4125","LU2746668974.SGD","LU0823416689.USD","IE00BJJMRY28.SGD","WDNA","LU2063271972.USD","LU2112291526.USD","LU0640476718.USD","LU2211817866.USD","SG9999014898.SGD","LU1366192091.USD","MEDX","KROP","LU0122379950.USD","XLV","SG9999001176.USD","LU2756315318.SGD","LU1267930730.SGD","LU2552382215.SGD","LU0353189763.USD","LU0648001328.SGD","LU0654597011.USD","LU1430597077.USD","LU0058720904.USD","LU0672654240.SGD","BK4093","LU0300736062.USD","LU1093756168.USD","LU0158827948.USD","HRTS","LU1280957306.USD","LU1691799644.USD","LU2324357040.USD","LU2746668461.USD","LU1974910355.USD","SG9999001176.SGD","LU2168564149.EUR","SGXZ99366536.SGD","LU2237438978.USD","LU1868836757.USD","BK4108","LU0320765992.SGD","LU2111349929.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716311","title":"Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716311","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716311?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:05","pubTimestamp":1790935529,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaqu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-announces-two-year-data-from-phase-3-iconic-total-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1551013342.USD","MEDX","FHLC","FTXH","JNJ","LU2505996509.AUD","IE00BJT1NW94.SGD","LU2236285917.USD","BMED","LU0466842654.USD","LU1732800096.USD","IXJ","XLV","SG9999013999.USD","IYH","LU1496350502.SGD","BK4588","RXL","LU1043141396.HKD","IE000WAW04H5.SGD","LU0994945656.USD","BK4581","LU0162691827.USD","VHT","LU0640476718.USD","LU0203345920.USD","LU2417539215.USD","BK4592","SGXZ57979304.SGD","IE00BDGV0183.EUR","PJP","BK4534","LU2468319806.SGD","GDOC","LU0426412945.USD","LU1066053197.SGD","SG9999002224.SGD","IE00B19Z3B42.SGD","IHE","JDOC","LU0738911758.USD","LU2430703251.USD","LU2471134952.CNY","IE0002270589.USD","TRUH","LU1551013425.SGD","LU0234570918.USD","LU2896262040.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715109","title":"Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715109","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715109?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:01","pubTimestamp":1790935267,"startTime":"0","endTime":"0","summary":"Johnson & Johnson says ICOTYDE sustains psoriasis skin clearance through 2 years in Phase 3 ICONIC-TOTAL studyJohnson & Johnson disclosed new two-year Phase 3 ICONIC-TOTAL results for ICOTYDE (icotrok","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8bWfkV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","IE0000B7K699.USD","LU1629891620.HKD","TRUH","JDOC","LU1430594728.SGD","IE00B4R5TH58.HKD","LU2430703251.USD","VHT","JNJ","RXL","SG9999002224.SGD","LU1066051225.USD","IYH","MEDX","IXJ","SG9999001440.SGD","LU1061106388.HKD","LU0994945656.USD","FHLC","LU2456880835.USD","LU0162691827.USD","LU2417539215.USD","IHE","PJP","LU1732800096.USD","LU1043141396.HKD","LU2129689605.HKD","LU0738911758.USD","IE00BJT1NW94.SGD","LU2896262040.SGD","SG9999001176.USD","LU0426412945.USD","LU1066051811.HKD","IE0034235303.USD","LU2347655156.SGD","LU1674673691.USD","GDOC","IE00BLSP4452.SGD","IE0009355771.USD","LU1043141123.HKD","XLV","IE00BBT3K403.USD","IE00BSNM7G36.USD","BMED","LU0234572021.USD","FTXH","LU0072461881.USD","LU0820561818.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971590","title":"J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971590?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0162691827.USD","IYH","FTXH","LU1551013425.SGD","XLV","LU0795875169.SGD","LU0057025933.USD","LU0912757837.SGD","LU1496350502.SGD","LU0426417589.USD","IE00BFTCPJ56.SGD","LU2129689605.HKD","LU1162221912.USD","FHLC","LU0426412945.USD","LU0820561909.HKD","LU1121112475.USD","LU0072461881.USD","LU1221951046.USD","LU1989771016.USD","IXJ","JNJ","IE00B19Z3581.USD","MEDX","PJP","LU0820562030.AUD","LU1066051498.USD","VHT","LU1674673691.USD","IE00B4R5TH58.HKD","LU0320765646.SGD","LU0882574055.USD","TRUH","LU2471134879.HKD","LU1551013342.USD","LU2347655156.SGD","LU1061106388.HKD","IHE","LU0234572021.USD","BK4568","GDOC","JDOC","RXL","IE0001KFT4U8.USD","IE00BLSP4452.SGD","LU1935042991.SGD","BMED","SGXZ80539844.SGD","BK4581","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672900715","title":"Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672900715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672900715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0432979614.USD","LU0792757196.USD","LU1228905037.USD","LU1430594728.SGD","LU0889566641.SGD","LU0070217475.USD","LU0203347892.USD","LU2750360641.GBP","JNJ","RXL","IE00BKVL7J92.USD","BK4581","LU1066051225.USD","LU1551013342.USD","JDOC","BMED","IE00BVYPNV92.GBP","BK4550","LU1989771016.USD","LU0122379950.USD","LU1267930813.SGD","LU0203345920.USD","LU0820561909.HKD","LU0511384066.AUD","XLV","FTXH","IE00BSNM7G36.USD","GDOC","LU0820562030.AUD","BK4568","IE00BVYPNW00.USD","IE0009355771.USD","LU1221951129.SGD","PJP","IE00BDGV0183.EUR","LU1674673691.USD","LU0234570918.USD","LU0882574055.USD","LU1066053197.SGD","VHT","LU0472753341.HKD","LU1003077747.HKD","TRUH","IHE","IYH","IE00BGHQF631.EUR","MEDX","FHLC","IXJ","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715972","title":"J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715972?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0162691827.USD","IE000BZT7R73.USD","FTXH","IYH","LU1551013425.SGD","LU1983299246.USD","XLV","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","BK4588","LU1043141123.HKD","IE00BN8TJ469.HKD","FHLC","LU1506573853.SGD","LU0072461881.USD","LU0210528500.USD","SG9999002232.USD","IXJ","JNJ","PJP","MEDX","LU0820562030.AUD","LU0964807845.USD","VHT","LU2505996681.GBP","IE000F7OJYX1.SGD","IE00B19Z3B42.SGD","LU0345769128.USD","LU0882574055.USD","TRUH","LU1074936037.SGD","LU2456880835.USD","LU1914381329.SGD","LU2471134879.HKD","IE000MB6IJN5.SGD","IE00B1BXHZ80.USD","LU0545562505.USD","IHE","LU2129689514.USD","GDOC","JDOC","RXL","LU1267930813.SGD","LU0203347892.USD","LU0345770993.USD","LU1145028129.USD","BMED","LU1221951129.SGD","BK4581","LU1732800096.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171597","title":"J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171597?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:00","pubTimestamp":1790935203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O09I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0472753341.HKD","LU1221951129.SGD","LU0122379950.USD","LU1066051225.USD","JDOC","LU0795875086.SGD","LU0820561909.HKD","TRUH","MEDX","RXL","BMED","LU0070217475.USD","BK4581","LU0889566641.SGD","LU0203347892.USD","IE00BSNM7G36.USD","LU1066053197.SGD","PJP","IE00BGHQF631.EUR","BK4568","IHE","IE00BVYPNV92.GBP","LU0432979614.USD","LU0820562030.AUD","LU1003077747.HKD","FTXH","XLV","GDOC","IYH","IE00BVYPNW00.USD","FHLC","LU0203345920.USD","LU1551013342.USD","LU1228905037.USD","LU2750360641.GBP","VHT","LU1674673691.USD","LU0234570918.USD","IE00BDGV0183.EUR","LU1267930813.SGD","IE00BKVL7J92.USD","IE0009355771.USD","BK4550","JNJ","LU0511384066.AUD","LU0882574055.USD","IXJ","LU1430594728.SGD","LU1989771016.USD","LU0792757196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BFSS8Q28.SGD","LU0225283273.USD","IE00BKVL7J92.USD","LU0109391861.USD","SG9999014898.SGD","LU1481599808.USD","LU0499090636.EUR","LU1993786604.SGD","LU0607220059.USD","LU0122379950.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BQJZX424.USD","LU1496350502.SGD","IE0008369823.USD","LU2360032135.SGD","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","NVOC","LU1273509221.SGD","LU1244550494.USD","LU2580892862.HKD","LU1035775433.USD","AZN.UK","SG9999004220.SGD","IE00BJT1NW94.SGD","LU2596442595.SGD","LU0053666078.USD","LU0889565080.SGD","LU0109981661.USD","LU2552382132.HKD","LU1116320737.USD","WDNA","LU1019634622.SGD","BK1161","LU0203202063.USD","LU0289739343.SGD","LU0889566641.SGD","LU0540923850.HKD","LU1720051017.SGD","LU2125154935.USD","IE00BKDWB100.SGD","LU1066051811.HKD","LU1974910355.USD","LU2129689605.HKD","LU0266013472.USD","LU0795875086.SGD","LU0823416689.USD","IE00B4JS1V06.HKD","LU2362541513.USD","LLYZ","LU0997586515.USD","LU2097828474.EUR","LU2362541273.HKD","BK0183","HK0000165453.HKD","LU2491050154.USD","PFE","IE00B19Z3B42.SGD","LU1983299246.USD","THNR","09995","LU1496350171.SGD","LU1807302812.USD","LU0323591593.USD","BK0196","LU2039709279.SGD","LU0154236417.USD","BK0012","LU1400636657.SGD","IE00B42XCP33.USD","LU0417516738.SGD","IE00BK4W5L77.USD","LU1019632923.USD","LU2028103732.USD","LU1551013425.SGD","LU2646069778.SGD","IE00BK4W5M84.HKD","LU0997586432.USD","LU0072913022.USD","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0965509283.SGD","LU1226288170.HKD","LU0096364046.USD","LU0345777147.USD","LU0472753341.HKD","LU0385154629.USD","LU1934455277.USD","BK1593","LU2091194634.USD","LU1989772840.SGD","LU0244354667.USD","LU1670756490.USD","SG9999014906.USD","IE000F7OJYX1.SGD","01093","LU1880407132.USD","BK4007","LU2750360997.AUD","LU0575583348.USD","LU0140636845.USD","KURE","BK1515","LU2236285917.USD","BNTX","LU1813983027.USD","LU0321505868.SGD","LU0158827948.USD","LU0238689110.USD","01801","IE0008368742.USD","LU2468319806.SGD","IE00BZ08YR35.GBP","BK4516","TRUH","LU2242652126.USD","LU0058720904.USD","LU1202635105.USD","AGNG","LU0942090050.USD","SG9999015986.USD","REGN","IE00BLSP4239.USD","BK1588","LU0158827781.USD","LU1003076772.USD","LU0784385840.USD","LU0211326839.USD","LU0784385170.HKD","LU0553294199.USD","LU0545562505.USD","LU2097828805.USD","LU2488822045.USD","LU1894683264.USD","LU0496365809.HKD","LU2125154778.USD","LU2237443382.USD","LU2462591350.SGD","GDOC","LU2097828714.EUR","02096","LU3187612489.SGD","LU0963555726.SGD","LU2360106947.USD","LU0784383803.USD","RHHBY","MEDI","IE00BFXG1179.USD","LU1585245621.USD","LU0985320562.USD","LU2471134879.HKD","IE000M9KFDE8.USD","SG9999003800.SGD","SG9999017495.SGD","LU0237698245.USD","LU0070302665.USD","OZEM","688506","600276","LU2580892789.USD","LU0417516571.SGD","IE00B2B36J28.USD","LU0823434583.USD","LU0757432116.USD","IE0034235071.USD","LU0964806797.USD","LU2089283258.USD","LU1820825898.SGD","LU2347655073.USD","LU0211327993.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU0708994859.HKD","LU0161305163.EUR","LU2471134952.CNY","LU2750360641.GBP","IE00B5MMRT66.SGD","LU0820561818.USD","SG9999018865.SGD","LU0920783379.SGD","LU0267386448.USD","LU1066053197.SGD","VHT","LU1032466523.USD","LU0079474960.USD","IE00BGHQF631.EUR","IYH","LU2746668461.USD","IE00BKPKM643.USD","LU2087625088.SGD","LU2756315318.SGD","LU2476274308.USD","LU0149534421.HKD","BK4139","LU2087621335.USD","IBBQ","LU1152091168.USD","LU2097828631.EUR","LU2462157665.USD","LU1934455863.HKD","LU2063271972.USD","LU1146622755.USD","LU1064131003.USD","BK4581","LU1015430645.USD","LU1323610961.USD","LU2476274720.SGD","LU0011850046.USD","LU1145028129.USD","LU2433249047.HKD","LU0097036916.USD","LU0171293334.USD","LU1037948541.HKD","LU0857590862.USD","LU2552382058.USD","LU2023250504.SGD","LU1226287875.USD","LU0969580561.USD","IE00BZ08YT58.USD","MEDX","LU1153585028.USD","LU0689472784.USD","PJP","IE00BZ08YS42.EUR","LU0348825331.USD","LU0972486137.USD","NVS","LU0949170772.SGD","RXL","BK0060","LU1051770623.HKD","LU0162691827.USD","LU1064131342.USD","LU0225771236.USD","IE00BJJMRY28.SGD","LU1232071149.USD","LU1571399168.USD","LU1153584641.USD","LU0827474353.SGD","LU1670711040.USD","BK0239","LU0320765992.SGD","LU2756315664.SGD","LU0880133367.SGD","03692","LU1061106388.HKD","LU1794554557.SGD","ELIL","LU1868836914.USD","LU0920840948.USD","LU1804176565.USD","LU0501845795.SGD","BK5011","LU1720051108.HKD","LU0882574139.USD","LU2289578879.USD","LU2361044949.HKD","SGXZ99366536.SGD","LU2399975544.HKD","LU0987226296.USD","LU0980610538.SGD","PAWZ","09926","LU2106854487.HKD","LU0965508806.USD","IE00BJJMRX11.SGD","LU0069063385.USD","LU0124676726.USD","LU0320765059.SGD","LU1098665638.USD","IE0004445015.USD","LU1196032939.SGD","BK4548","CANC","LU1078025761.USD","LU1868836757.USD","LU1969619763.USD","LU1691799644.USD","SGXZ81514606.USD","LU0861579265.USD","LU0289961442.SGD","IE0000B7K699.USD","LU0466842654.USD","LU0310800965.SGD","LU2089984988.USD","LU1712237335.SGD","LU2133065610.SGD","LU0114720955.EUR","LU1037948897.HKD","LU2213496289.HKD","LU0320765646.SGD","LU2491049909.HKD","SG9999002232.USD","SG9999011175.SGD","SGXZ51526630.SGD","LU0405327148.USD","SG9999002224.SGD","LU0061475181.USD","LU1035773651.USD","LU0067412154.USD","BK0188","LU2237443465.HKD","IE00BWDBJ516.SGD","LU1057294990.SGD","LU1236620750.USD","LU1894683348.USD","LU1226287792.SGD","LU1255011170.USD","LU0133085943.USD","LU1670627923.USD","LU2108987350.USD","LU0557290698.USD","LU1580142542.USD","SG9999015945.SGD","IE00B3PB1722.GBP","LU2279689827.SGD","SGXZ57979304.SGD","LU0348784397.USD","LU2125909247.SGD","SG9999014914.USD","NVOH","BK4568","LU0211326755.USD","LU1829250122.USD","LU0390134368.USD","LU0683600562.USD","SG9999015952.SGD","LU0502904849.HKD","LU1023059063.AUD","IHE","LU2539964713.USD","LU2552382215.SGD","LU1481600234.SGD","IE0001KFT4U8.USD","LU0171276677.USD","LU2242646821.SGD","688331","LU1066051498.USD","LU0545039389.USD","SG9999015341.SGD","LU0316494557.USD","IE00BN29S564.USD","LU2211815571.USD","LU1064130708.USD","LU0348827113.USD","LU0726765562.USD","LU0128525689.USD","LU0348766576.USD","SG9999014567.USD","LU2125909593.SGD","LU0094547139.USD","LU1400636574.HKD","IE00B3M56506.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU0792757196.USD","IBB","LU1670628061.USD","LU2129689431.USD","SG9999001440.SGD","BK4585","LU0738911758.USD","LU0957799991.USD","LU0971552673.USD","LU2114397693.USD","LU1366192091.USD","SG9999014559.SGD","SG9999015358.SGD","SGXZ31699556.SGD","LLYX","LU1170363599.USD","SMMT","LU1035777561.USD","LU1328277881.USD","LU1267930227.SGD","LU1119994496.HKD","IE00BJLML261.HKD","SG9999001176.USD","LU2602419157.SGD","LU0912757837.SGD","LU1291159041.SGD","LU2111349929.HKD","LU1162221912.USD","LU0964807845.USD","LU0417517546.SGD","LU0648001328.SGD","LU0689626769.HKD","LU0310800379.SGD","LU0345770308.USD","LU0887340254.USD","LU1951186391.HKD","LU0130517989.USD","IE000BZT7R73.USD","LU1093756325.SGD","BK4533","LU1863844665.USD","LU0072461881.USD","BK0028","IE00BKPKM429.USD","LU0211331839.USD","LU0047473722.SGD","SG9999014542.SGD","BK1191","LU0106261372.USD","BMED","LU0130102774.USD","LU1430594728.SGD","LU1655091616.SGD","LU1645745479.HKD","LU0455707207.USD","LU0949170426.SGD","LU1046248800.SGD","SG9999001176.SGD","IE000MB6IJN5.SGD","LU0960981461.USD","LU2357627491.SGD","IE00BFTCPJ56.SGD","LU1863844749.USD","LU0234570918.USD","MHIP","BK1589","LU0471298694.HKD","GLAM","LU0395794307.EUR","LU2361045086.USD","LU1960683339.HKD","00013","IE0005OL40V9.USD","LU1839511570.USD","JDOC","LU0265550359.USD","LU2461242641.AUD","LU2324357040.USD","LU2112291526.USD","LU0057025933.USD","IE000SO60NU8.SGD","LU0077335932.USD","LU1074936037.SGD","LU0310799852.SGD","LU1629891620.HKD","LU0405327494.USD","LU0985481810.HKD","LU0795875169.SGD","LU1883839398.USD","LU0320765489.SGD","LU1997245177.USD","LU0321505439.SGD","LU1880407215.USD","IE00BDGV0183.EUR","LU0882574055.USD","LU0098860793.USD","LU0868494708.USD","LU2237443622.USD","IE00B19Z3581.USD","LU0820562030.AUD","LU0345777659.USD","LU1104425308.USD","LU1988902786.USD","LU2778985437.USD","TMED","LU2168564222.USD","LU2362540622.SGD","LU0174119429.USD","03933","LU0354030438.USD","LU0526926950.USD","LU0203347892.USD","LU1267930813.SGD","SG9999015978.USD","LU1989771016.USD","IE00BVYPNW00.USD","SG9999014575.USD","LU0820561909.HKD","LU1267930730.SGD","01530","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU0170899867.USD","LU1228905540.USD","LU0198837287.USD","LU1718418525.SGD","LU2168564149.EUR","03165","LU1355424745.HKD","LU0210536198.USD","LU1226287529.USD","IE00BWXC8680.SGD","LU2089284900.SGD","LU1720050803.USD","LU0859254822.USD","LU2357305700.SGD","LU0306806265.USD","LU1244550221.USD","FTXH","IE00BLSP4452.SGD","IE0009355771.USD","BMY","LU0256863902.USD","LU0315179316.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU1236620834.HKD","LU2023251221.USD","LU2271345857.HKD","GSK.UK","CURE","LU0353189680.USD","LU1309081286.SGD","LU0823434740.USD","ELIS","LU0029864427.USD","LU1066051225.USD","LU0477156953.USD","NVO","SG9999013999.USD","IE00BFSS7M15.SGD","IE00B3T34201.USD","IE0034235188.USD","LU1868836591.USD","LU2168564065.EUR","LU1979441026.SGD","LU1917777945.USD","BK4532","LU0225284248.USD","LU2023250843.SGD","IE00B4R5TH58.HKD","LU1201861249.SGD","IE00B543WZ88.USD","ILDR","LU0256863811.USD","LU2495084118.USD","SG9999018857.SGD","LU1548497426.USD","LU1400636491.USD","LU1226288253.USD","LU1301847155.USD","HCM","LU2896262040.SGD","FHLC","LU0463099449.HKD","NVOX","LU0471298777.SGD","LU2242644610.SGD","IE0002270589.USD","LU2746668974.SGD","LU2023250330.USD","LU2293690082.USD","LLII","BK1587","IE00B031HY20.USD","IXJ","LU0889565916.HKD","ABBV","PPH","LU0203201768.USD","LU1732799900.SGD","BK1574","LU1152091754.HKD","LU1046234339.USD","LU2456880835.USD","LU1084165304.USD","LU1868837136.USD","LU1551013342.USD","LU1941712348.USD","LU0128525929.USD","IE00BZ1G4Q59.USD","BK4551","LU0265550946.USD","LU0289739699.SGD","LU0787776722.HKD","LU1069347547.HKD","IE0004445239.USD","LU1188198961.HKD","LU2237443978.SGD","BK1521","HRTS","LU1732800096.USD","MRK","BK4592","LU0047473722.EUR","LU1116320901.HKD","LU1997244956.HKD","LU2129689514.USD","IE00BPRC5H50.USD","LU1069344957.HKD","LU0348767384.USD","LU0943347566.SGD","LU1328615791.USD","LU0306807586.USD","LU1929549753.HKD","BK4566","BK4550","LU2328871848.SGD","BK1583","LU0976567544.SGD","LU2355687059.USD","LU2237438978.USD","LU0511384066.AUD","LU1934455194.USD","BK4599","BK4534","LU1302929846.USD","BK4588","LU1127390331.HKD","TBXU","LU1487256676.USD","LU1670710661.SGD","LU1008478684.HKD","LU0348735423.USD","LU1064927863.SGD","LU0345770993.USD","LU0211328371.USD","LU0672654240.SGD","IE00B7KXQ091.USD","LU0965509101.SGD","BK4578","LU0786609619.USD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","BK4559","LU1093756168.USD","LU1267930573.SGD","BBH","IE000WAW04H5.SGD","LU1228905037.USD","01276","LU0823399737.USD","LU0234572021.USD","LU0868494617.USD","LU0561508036.HKD","LU1261432733.SGD","LU1699723380.USD","LU1831875114.USD","LU0326950275.SGD","LU0965509010.AUD","LU0417516902.SGD","LU1003077747.HKD","LU1781817850.SGD","LU1961090484.USD","LU2237443549.SGD","LU2471134523.USD","LU0784384876.USD","LU1989772923.USD","LU0640478417.SGD","IE00BSNM7G36.USD","LU0052756011.USD","LU2148510915.USD","IE0002141913.USD","SG9999014880.SGD","LU2471134796.USD","LU2417539215.USD","LU1670710588.SGD","LU0208291251.USD","LU0348783233.USD","IE00B1XK9C88.USD","LU1670711123.USD","LU2491050071.SGD","LLY","LU1923622614.USD","XLV","LU0314109678.HKD","LU1244550577.SGD","LU0634319403.HKD","GB00BDT5M118.USD","LU2237443895.HKD","LU1997245094.SGD","LU2293690249.USD","LU1941712264.USD","LU1267930490.SGD","LU2265009873.SGD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","LU0971552830.HKD","LU1868837300.USD","IE00BBT3K403.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0949170772.SGD","AGNG","LU0057025933.USD","LU1244550577.SGD","LU2112291526.USD","LU1917777945.USD","PFE","LU0158827948.USD","MEDX","FTXH","LU0211327993.USD","IE00BJT1NW94.SGD","IBB","LU1037948541.HKD","TRUH","LU2106854487.HKD","VHT","ABBV","LU0098860793.USD","LU2347655073.USD","TBXU","SNY","BK4599","BK4585","LU0965509283.SGD","IBBQ","FHLC","LU0795875169.SGD","REGN","OZEM","LU0128525929.USD","XLV","IXJ","JDOC","GLAM","LU0053666078.USD","LU1883839398.USD","IYH","PJP","BBH","LU1057294990.SGD","LU0069063385.USD","LU2133065610.SGD","PPH","LU1720051108.HKD","LU0203347892.USD","LU0029864427.USD","SNYNF","LU0417517546.SGD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790916","title":"Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790916","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790916?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:57","pubTimestamp":1790927874,"startTime":"0","endTime":"0","summary":"UPDATE 3-Novartis strikes up to $7.8 billion mRNA deal with China's AbogenOct 2 (Reuters)-Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","LU0070302665.USD","LU2106854487.HKD","HRTS","LU0162691827.USD","LU0203347892.USD","VHT","TRUH","LU1430594728.SGD","JDOC","LU1261432733.SGD","BK4007","PAWZ","AZN.UK","LU0171293334.USD","BMED","PPH","IHE","LU1814569148.SGD","LU0823416689.USD","FHLC","LU0920783379.SGD","LU1291159041.SGD","LU1989771016.USD","MRK","GDOC","IE00BKPKM643.USD","LU0011850046.USD","MRNX","IDNA","LU0757432116.USD","LU0942090050.USD","LU1880407132.USD","LU1051770623.HKD","LU2112291526.USD","IE00BLSP4239.USD","IYH","MRNA","RXL","03165","FTXH","LU0098860793.USD","IXJ","MRNY","XLV","GNOM","SGXZ57979304.SGD","LGHT","SG9999015358.SGD","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672916767","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672916767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672916767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:28","pubTimestamp":1790890080,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 5.01% to $14.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's fourth consecutive day of losses.Perrigo Co. PLC closed 38.10% below its 52-week high of $22.65, which the company reached on October 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Procter & Gamble Co.  fell 0.92% to $143.95, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 247,637 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU1718418525.SGD","JNJ","LU0069063385.USD","SGXZ80539844.SGD","LU1721429402.USD","LU1721429741.USD","IE000F7OJYX1.SGD","GDOC","IYH","SG9999002232.USD","IE00B19Z3581.USD","LU1506573853.SGD","SGXZ23171101.USD","LU1162221912.USD","IHE","XLP","FTXH","TRUH","LU0994945656.USD","MEDX","ABT","LU2552382132.HKD","LU0345769631.USD","UGE","IE00B3PB1722.GBP","LU2112291526.USD","BK4534","TRUO","IHI","XLV","IE000WAW04H5.SGD","LU0289961442.SGD","LU1043141396.HKD","PG","FHLC","SG9999015341.SGD","IXJ","VHT","JDOC","LU1221951129.SGD","BMED","LU0289739343.SGD","LU1551013425.SGD","LU0289739699.SGD","RXL","TMED","IE00BLSP4452.SGD","PRGO","FSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672626227","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672626227","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672626227?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887020,"startTime":"0","endTime":"0","summary":"DJ Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slipped 1.51% to $61.46 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's third consecutive day of losses.Bristol Myers Squibb Co. closed 10.46% short of its 52-week high of $68.64, which the company achieved on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Pfizer Inc.  fell 1.40% to $28.12, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 507,251 below its 50-day average volume of 11.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU0225284248.USD","BK4588","BK4581","LU1670711123.USD","LU2360032135.SGD","LU0237698245.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU0267386448.USD","LU1032466523.USD","LU1718418525.SGD","LU1670710661.SGD","LU0882574055.USD","LU1093756325.SGD","LU1670710588.SGD","LU1236620834.HKD","LU1323610961.USD","BK4559","LU1868837300.USD","LU1868836757.USD","LU0096364046.USD","BK4585","LU1989771016.USD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU0321505868.SGD","LU0985481810.HKD","LU1074936037.SGD","IE0009355771.USD","LU1430594728.SGD","LU1571399168.USD","BMY","LU1585245621.USD","FTXH","LU0321505439.SGD","LU0432979614.USD","LU1868836914.USD","LU2125154778.USD","IE0002141913.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU2596442595.SGD","BK4007","LU0061475181.USD","BK4534","IE00BFXG1179.USD","LU1883839398.USD","LU0225771236.USD","LU2242646821.SGD","IHE","LU1236620750.USD","LU1261432733.SGD","LU0456855351.SGD","LU1093756168.USD","LU1670711040.USD","LU2133065610.SGD","BK4532","LU1868837136.USD","LU0306807586.USD","LU1868836591.USD","LU2125154935.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762679","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762679","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762679?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:33","pubTimestamp":1790886780,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.03% to $143.81 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 8.35% short of its 52-week high of $156.92, which the company reached on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Pfizer Inc.  fell 1.40% to $28.12, and Eli Lilly & Co.  fell 0.62% to $1,149.85.Trading volume  remained 2.2 million below its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0265550946.USD","LU0965508806.USD","LU1057294990.SGD","LU0070302665.USD","LU1571399168.USD","LU2125909593.SGD","LU2125154935.USD","LU0234572021.USD","LU0859254822.USD","LU2125909247.SGD","GDOC","SG9999015358.SGD","LU2361045086.USD","LU2023250843.SGD","LU1162221912.USD","IE00B2B36J28.USD","LU2468319806.SGD","BK4007","IE00BLSP4452.SGD","LU0868494708.USD","IE00BN8TJ469.HKD","LU1934455863.HKD","LU0203345920.USD","LU2361044949.HKD","LU0130102774.USD","LU1093756168.USD","IE00BBT3K403.USD","LU2125154778.USD","LU1116320737.USD","BK4534","IXJ","LU1116320901.HKD","LU2361044865.SGD","LU1061106388.HKD","LU2357627491.SGD","SG9999002232.USD","LU1974910355.USD","LU0266013472.USD","BK4533","SG9999015341.SGD","HRTS","LU1989771016.USD","LU1066051225.USD","LU1941712348.USD","XLV","LU1291159041.SGD","LU0265550359.USD","LU0472753341.HKD","LU1066051498.USD","LU1929549753.HKD","SG9999001176.SGD","LU0965509101.SGD","LU1066053197.SGD","LU0203347892.USD","LU0965509283.SGD","BK4588","LU0058720904.USD","LU0868494617.USD","LU1201861249.SGD","LU0980610538.SGD","LU0432979614.USD","LU1069347547.HKD","LU2461242641.AUD","LU1037948541.HKD","LU1934455194.USD","LU0106261372.USD","LU0208291251.USD","LU1035773651.USD","LU1989772840.SGD","SG9999014575.USD","IYH","LU0130517989.USD","LU2360032135.SGD","LU0069063385.USD","RXL","SGXZ57979304.SGD","SG9999002224.SGD","BK4559","IE00BSNM7G36.USD","LU2491050071.SGD","TRUH","LU0124676726.USD","LU0689626769.HKD","LU2089984988.USD","IE00BLSP4239.USD","SG9999001440.SGD","LU0511384066.AUD","LU1430594728.SGD","LU0985320562.USD","LU1093756325.SGD","LU1941712264.USD","MRK","LU0861579265.USD","LU1023059063.AUD","LU1983299246.USD","SG9999001176.USD","LU0320765646.SGD","LU2112291526.USD","FTXH","LU0942090050.USD","LU0320765489.SGD","LU1066051811.HKD","SG9999013999.USD","BK4585","LU2491049909.HKD","PPH","IE000M9KFDE8.USD","LU0211331839.USD","IE0002141913.USD","LU2106854487.HKD","LU0823416689.USD","IHE","IE00BJJMRZ35.SGD","LU0289739343.SGD","LU1699723380.USD","SG9999014542.SGD","LU0162691827.USD","LU2491050154.USD","LU1917777945.USD","LU1585245621.USD","LU1934455277.USD","JDOC","IE00BJT1NW94.SGD","LU0289961442.SGD","BMED","LU0057025933.USD","SG9999014567.USD","LU1923622614.USD","LU2433249047.HKD","LU1032466523.USD","LU0122379950.USD","VHT","LU0238689110.USD","LU0072461881.USD","LU0965509010.AUD","PAWZ","LU0098860793.USD","LU0289739699.SGD","LU2324357040.USD","IE0009355771.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","BK4550","LU0648001328.SGD","LU1037948897.HKD","FHLC","IE00B4R5TH58.HKD","LU0477156953.USD","LU0006306889.USD","SG9999014559.SGD","LU1989772923.USD","BK4516","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672783761","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672783761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672783761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:29","pubTimestamp":1790882992,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.6%.In corporate news, Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909 into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial. Foghorn shares fell 16%, and Lilly was down 0.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PJP","LU2491049909.HKD","LU2028103732.USD","LU0096364046.USD","LU0256863902.USD","LLY","SG9999018857.SGD","SGXZ51526630.SGD","GDOC","SG9999017495.SGD","BK4516","IYH","SGXZ81514606.USD","ELIS","LU1291159041.SGD","WDNA","LU0109394709.USD","LU2746668461.USD","IHE","LU1064131342.USD","LU0158827781.USD","BK4139","LU0823434583.USD","MEDI","LU2471134879.HKD","LU0353189680.USD","IE0004445239.USD","LU2360106947.USD","LU2265009873.SGD","LU2471134523.USD","LU2552382132.HKD","LU2112291526.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","SG9999013999.USD","LU0943347566.SGD","BK4599","LU1267930730.SGD","IE00B1BXHZ80.USD","FHTX","FHLC","LU0097036916.USD","LU1093756168.USD","LU1868837300.USD","LU0316494557.USD","LU2361044949.HKD","LU2237443382.USD","LU1720051017.SGD","LU0210536198.USD","SG9999001176.SGD","LU2896262040.SGD","SG9999015945.SGD","LLYX","LU1061106388.HKD","LU0106261372.USD","LU0234572021.USD","LU2361045086.USD","IE00B775H168.HKD","LLII","LU1551013425.SGD","LU2106854487.HKD","LU2237443895.HKD","LU2023250504.SGD","LU1232071149.USD","CANC","IE0009355771.USD","LU1629891620.HKD","LU1868836757.USD","LU1917777945.USD","LU2237443465.HKD","SG9999001176.USD","OZEM","SG9999014914.USD","LU0683600562.USD","LU0345770308.USD","LU2471134796.USD","LU0094547139.USD","LU2236285917.USD","IE0005OL40V9.USD","LU2468319806.SGD","LU0471298777.SGD","LU1814569148.SGD","LU0417517546.SGD","LU1983299246.USD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","IE0002141913.USD","LU1868836591.USD","SGXZ57979304.SGD","LU0823434740.USD","AGNG","IE00BN29S564.USD","THNR","BK4534","LU2023250330.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0354030511.USD","LU2237438978.USD","LU2111349929.HKD","LU0708995401.HKD","LU2462591350.SGD","LU2361044865.SGD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2237443549.SGD","LU2237443978.SGD","LU2324357040.USD","LU2491050154.USD","VHT","LLYZ","LU0203202063.USD","LU0466842654.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1989771016.USD","LU1280957306.USD","LU0122379950.USD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU0289739699.SGD","LU1623119135.USD","IE00BJJMRX11.SGD","LU2087625088.SGD","LU2108987350.USD","SGXZ31699556.SGD","SGXZ99366536.SGD","TMED","LU0174119429.USD","LU0320765059.SGD","LU0354030438.USD","HRTS","LU1366192091.USD","LU1145028129.USD","LU0889565916.HKD","SG9999014906.USD","LU1551013342.USD","LU2168564065.EUR","LU2213496289.HKD","LU0456855351.SGD","IE00B2B36J28.USD","LU2552382215.SGD","LU2461242641.AUD","LU1057294990.SGD","IE0004445015.USD","XBI","FTXH","LU0882574139.USD","TRUH","LU0256863811.USD","MEDX","LU2491050071.SGD","LU0823416689.USD","CURE","LU0640476718.USD","LU0198837287.USD","LU2750360641.GBP","XLV","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2462157665.USD","IXJ","IE00BKDWB100.SGD","LU1323610961.USD","IE00B4JS1V06.HKD","LU2089284900.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0158827948.USD","JDOC","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","LU0079474960.USD","MHIP","LU0320765992.SGD","RXL","SG9999015952.SGD","LU2471134952.CNY","LU0109391861.USD","SG9999014898.SGD","LU1548497426.USD","LU1720051108.HKD","LU2357305700.SGD","IBB","LU2063271972.USD","LU0689472784.USD","LU0353189763.USD","LU1804176565.USD","LU1979441026.SGD","LU2168564222.USD","LU2552382058.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","LU0786609619.USD","LU0471298694.HKD","LU0964807845.USD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","LU2756315664.SGD","LU0672654240.SGD","SG9999014880.SGD","LU1127390331.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1691799644.USD","LU2264538146.SGD","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","PPH","BK4007","LABU","IE00BKPKM429.USD","LU2023251221.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","ELIL","LU0820561818.USD","LU2089283258.USD","LU1093756325.SGD","BK4533","IE00BWXC8680.SGD","LU1023059063.AUD","LU1035775433.USD","LU1868836914.USD","SG9999015986.USD","LU2271345857.HKD","LU2746668974.SGD","LU0385154629.USD","ILDR","LU0058720904.USD","LU0820562030.AUD","LU0133085943.USD","LU0238689110.USD","IE0001KFT4U8.USD","IE00BJLML261.HKD","LU1868837136.USD","LU2168564149.EUR","BK4588","LU2602419157.SGD","LU2456880835.USD","BK4585","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672480761","title":"AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672480761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672480761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:21","pubTimestamp":1790878886,"startTime":"0","endTime":"0","summary":"AbbVie’s AbbVie stock has had a strong multiyear run, and with the price recently closing at US$261.59, the key issue is whether that level is backed by the cash the business is expected to generate. Recent drug approvals, partnerships and data readouts all feed into those future cash flows, which is where the valuation debate now sits.\n\nOver the past 5 years AbbVie has delivered a total return of 187.5%, which puts real weight on the question of whether the current share price is fully...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B4R5TH58.HKD","BK4139","LU1244550221.USD","LU0859254822.USD","DCF","LU0965508806.USD","JDOC","SG9999011175.SGD","IXJ","LU2089984988.USD","MEDX","SPHQ","LU2125909593.SGD","RXL","LU2347655073.USD","ABBV","LU0114720955.EUR","TRUH","IYH","AGNG","LU1670628061.USD","BK4588","LABU","LU1989772840.SGD","XLV","LU1037948541.HKD","LU2433249047.HKD","PPH","LU1670627923.USD","PJP","LU0868494617.USD","LU0256863902.USD","LU1929549753.HKD","FTXH","LU0472753341.HKD","LU2125909247.SGD","LU0795875169.SGD","BK4533","LU1093756168.USD","FHLC","LU0689626769.HKD","LU2089284900.SGD","VHT","LU2129689514.USD","LU1430594728.SGD","LU0726765562.USD","BK4581","LU1720051017.SGD","GLAM","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":8,"totalSize":318,"code":"91000000","status":"200"}]}}